Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

GANX
Gain Therapeutics, Inc. Common Stock
stock NASDAQ

At Close
Oct 1, 2026 3:59:51 PM EDT
1.73USD0.000%(0.00)492,780
0.00Bid   0.00Ask   0.00Spread
Pre-market
Oct 1, 2026 9:29:30 AM EDT
1.78USD+2.890%(+0.05)6,822
After-hours
Oct 1, 2026 4:41:30 PM EDT
1.76USD+1.908%(+0.03)200
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 31, 2022
04:05PM EST  Gain Therapeutics, Inc. (Nasdaq: GANX) (Gain),a biotechnology company transforming the drug discovery paradigm with structurally targeted allosteric regulators identified with its proprietary computational discovery platform, today announced additional details on its R&D Day being held virtually on Friday, February 4, 2022 from 10:00 am 12:00 pm Eastern Time.   GlobeNewswire Inc
Jan 18, 2022
08:00AM EST  - Neuroscience and Beyond: Harnessing Computational Technology and Allosteric Modulators to Drug the Undruggable -- 18th Annual WORLDSymposium - AD/PD 2022 -   GlobeNewswire Inc
Jan 11, 2022
10:38AM EST  52 Weeks High And Low Article   Benzinga
Jan 6, 2022
04:05PM EST  Gain Therapeutics to Participate at the H.C.   GlobeNewswire Inc
Dec 28, 2021
04:05PM EST  Gain Therapeutics Reports Inducement Grants Under Nasdaq Listing   GlobeNewswire Inc
Dec 7, 2021
08:00AM EST  Gain Therapeutics Progresses Krabbe Disease Programand   GlobeNewswire Inc
Dec 1, 2021
04:08PM EST  Gain Therapeutics to Participate at the Imagine AI + Healthcare   GlobeNewswire Inc
Nov 12, 2021
07:22AM EST  Gain Therapeutics Q3 EPS $(0.39) Down From $(0.25) YoY, Sales $27.34M Up From $6.70M YoY   Benzinga
07:00AM EST  Gain Therapeutics, Inc. Reports Third Quarter 2021 Financial   GlobeNewswire Inc
Nov 11, 2021
11:00AM EST  Gain Therapeutics Presents Parkinsons Disease   GlobeNewswire Inc
Nov 10, 2021
11:00AM EST  Study results demonstrate first small molecule approach to significantly reduce phosphorylated and aggregated -synuclein and increase GCase protein levelswith transport to the lysosomes in iPSC dopaminergic neurons   GlobeNewswire Inc
Nov 3, 2021
10:03AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2021   Benzinga
09:11AM EDT  B. Riley Securities Initiates Coverage On Gain Therapeutics with Buy Rating, Announces Price Target of $21   Benzinga
Oct 28, 2021
08:00AM EDT  - The Michael J. Fox Foundations Parkinsons Disease Therapeutics Webinars -   GlobeNewswire Inc
Oct 26, 2021
08:00AM EDT  Gain Therapeutics, Inc. Announces Appointment of Five Members to   GlobeNewswire Inc
Oct 19, 2021
08:14AM EDT  Gain Therapeutics Appoints Matthias Alder As Chief Operating Officer   Benzinga
08:12AM EDT  Gain Therapeutics Appoints Matthias Alder As COO   RTTNews
08:00AM EDT  Gain Therapeutics Appoints Matthias Alder as Chief Operating Officer   GlobeNewswire Inc
Oct 12, 2021
10:07AM EDT  Gain Therapeutics' SEE-Tx Platform Shows Increasing Evidence in Treating Diseases Caused by Protein Misfolding   Benzinga
08:13AM EDT  The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology   Benzinga
Oct 7, 2021
08:24AM EDT  The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results   Benzinga
Sep 29, 2021
10:12AM EDT  From BZ's Small Cap Healthcare Conference: Gain Therapeutics CEO, Eric Richman Begin Presenting   Benzinga
Sep 23, 2021
08:00AM EDT  Gain Therapeutics to Present at the Cantor Virtual Global   GlobeNewswire Inc
Sep 21, 2021
08:20AM EDT  The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data   Benzinga
Sep 17, 2021
08:10AM EDT  Gain Therapeutics To Present At Oppenheimer Fall Healthcare Life Sciences, MedTech Summit Sept. 22 At 1:15 p.m. EDT   Benzinga
08:00AM EDT  Gain Therapeutics to Present at the Oppenheimer Fall Healthcare   GlobeNewswire Inc
Sep 15, 2021
07:38AM EDT  The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs   Benzinga
Sep 9, 2021
04:20PM EDT  Gain Therapeutics to Present at 2021 International Virtual GM1   GlobeNewswire Inc
Sep 8, 2021
03:51PM EDT  Why Gain Therapeutics Shares Are Trading Higher Today   Benzinga
07:33AM EDT  Gain Therapeutics, Inc. Announces Positive Topline Data in Patient-derived iPSC Study Evaluating STAR Compounds as a Treatment for Gaucher and Parkinson's Disease   Benzinga
07:29AM EDT  Gain Therapeutics, Inc. Announces Positive Topline   GlobeNewswire Inc
Sep 2, 2021
04:05PM EDT  Gain Therapeutics, Inc. to Present at the H.C. Wainwright 23rd   GlobeNewswire Inc
Aug 17, 2021
08:28AM EDT  The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business   Benzinga
Aug 11, 2021
04:13PM EDT  Gain Therapeutics Q2 EPS $(0.30) Down From $(0.27) YoY   Benzinga
04:01PM EDT  Gain Therapeutics, Inc.Reports Second Quarter 2021   GlobeNewswire Inc
Aug 3, 2021
04:05PM EDT  Gain Therapeutics to Present at the BTIG Virtual Biotechnology   GlobeNewswire Inc
07:55AM EDT  The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business   Benzinga
Jul 28, 2021
07:33AM EDT  The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal   Benzinga
Jul 16, 2021
07:37AM EDT  The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study   Benzinga
Jun 24, 2021
08:12AM EDT  The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO   Benzinga
Jun 10, 2021
07:34AM EDT  Gain Therapeutics Announces Issuance of Two New PCT Patents Covering GBA and GALC Modulator Compounds for Treatment of CNS Disorders   Benzinga
07:30AM EDT  Gain Therapeutics Announces Issuance of Two New PCT Patents   GlobeNewswire Inc
May 27, 2021
08:00AM EDT  Gain Therapeutics to Present at the Jefferies Virtual Healthcare   GlobeNewswire Inc
May 17, 2021
08:00AM EDT  Gain Therapeutics to Participate in Upcoming Virtual Investor   GlobeNewswire Inc
May 14, 2021
07:59AM EDT  The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts   Benzinga
May 12, 2021
08:57AM EDT  The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron   Benzinga
May 11, 2021
07:54AM EDT  The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings   Benzinga
May 10, 2021
04:19PM EDT  Gain Therapeutics Q1 EPS $(0.50) Down From $(0.29) YoY, Sales $5.27M Down From $6.67M YoY   Benzinga
04:01PM EDT  Gain Therapeutics, Inc. Reports First Quarter 2021 Financial Results   GlobeNewswire Inc
May 6, 2021
07:49AM EDT  The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom   Benzinga
May 3, 2021
07:30AM EDT  Compounds reverse the neurodegenerative process observed in a Parkinsons disease in vivo model   GlobeNewswire Inc
Apr 27, 2021
04:01PM EDT  Gain Therapeutics to Present at the B. Riley   GlobeNewswire Inc
Apr 22, 2021
08:00AM EDT  Gain Therapeutics Announces Presentation at the International   GlobeNewswire Inc
Apr 20, 2021
08:07AM EDT  Gain Therapeutics Announces Multi-Target Drug Discovery Collaboration Agreement With Zentalis Pharmaceuticals; Financial Details Not Disclosed   Benzinga
08:00AM EDT  Collaboration to use Gains proprietary Site-Directed Enzyme Enhancement Therapy (SEE-Tx) computational platform technology to identify new and previouslydifficult-to-drug oncology targets   GlobeNewswire Inc
Apr 14, 2021
07:00AM EDT  Coya Therapeutics Announces the Appointment of   GlobeNewswire Inc
Apr 13, 2021
08:16AM EDT  The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug   Benzinga
Apr 12, 2021
10:04AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2021   Benzinga
07:23AM EDT  Oppenheimer Initiates Coverage On Gain Therapeutics with Outperform Rating, Announces Price Target of $30   Benzinga
06:42AM EDT  BTIG Initiates Coverage On Gain Therapeutics with Buy Rating, Announces Price Target of $30   Benzinga
Apr 6, 2021
08:05AM EDT  The Daily Biotech Pulse: Illumina Lights Up, Cara Soars On Index Inclusion, Novavax Starts Crossover Vaccine Study, Turning Point Data Readout   Benzinga
Apr 1, 2021
07:46AM EDT  The Daily Biotech Pulse: Pfizer-BioNTech Preps For BLA Filing, Sonoma Surges, BioXcel Readout, Ortho Clinical Lands Contract   Benzinga
Mar 31, 2021
07:41AM EDT  The Daily Biotech Pulse: Pfizer Vaccine 100% Effective In Adolescents, Equillium Readout, Amgen Goes Shopping, Achilles IPO   Benzinga
Mar 30, 2021
08:06AM EDT  The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings   Benzinga
Mar 25, 2021
05:57PM EDT  Gain Therapeutics Announces Closing of Initial Public Offering and   GlobeNewswire Inc
Mar 24, 2021
08:59AM EDT  The Daily Biotech Pulse: Dynavax-Clover Start Phase 2/3 Vaccine Study. BrainStorm Reports Positive MS Readout, NeoGenomics Goes Shopping   Benzinga
Mar 22, 2021
12:28PM EDT  The IPO Market Had A Busy Week   Benzinga
Mar 18, 2021
11:13AM EDT  Gain Therapeutics Shares Open For Trade At $11.22; IPO Priced At $11/Share   Benzinga
09:08AM EDT  Gain Therapeutics Shares Will Open For Quote At 11:00 a.m. EDT, Expected To Open For Trade After 11:10 a.m. EDT; IPO Priced At $11/Share   Benzinga
07:15AM EDT  Gain Therapeutics Prices IPO Of 3.64 Mln Common Shares At $11/Shr   RTTNews
07:13AM EDT  Gain Therapeutics Prices IPO of ~3.6M Shares At $11/Share   Benzinga
07:00AM EDT  Gain Therapeutics Announces Pricing of Initial Public Offering of   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC